Table 3.
Crude rates of fatal (or life-threatening) bleeding from phase III trials comparing a TSOAC to standard therapy (usually warfarin)
HR indicates hazard ratio; CI, confidence interval; and N/R not reported.
Crude rates of fatal (or life-threatening) bleeding from phase III trials comparing a TSOAC to standard therapy (usually warfarin)
HR indicates hazard ratio; CI, confidence interval; and N/R not reported.
